StonvexLoading…
StonvexCore line items from PLSE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $350.00K | $0.00 | $0.00 | $700.00K |
Operating Income | $-76.94M | $-56.26M | $-43.57M | $-58.06M |
Net Income | $-72.78M | $-53.59M | $-42.21M | $-58.51M |
EPS (Diluted) | $-1.08 | $-0.92 | $-0.85 | $-1.72 |
Total Assets | $94.54M | $132.46M | $59.15M | $77.88M |
Total Liabilities | $13.88M | $17.60M | $14.79M | $80.13M |
Cash & Equivalents | $80.73M | $118.04M | $44.37M | $61.14M |
Free Cash Flow OCF − CapEx | $-54.44M | $-36.47M | $-33.16M | $-47.41M |
Shares Outstanding | 67.84M | 65.93M | 55.14M | 37.23M |